A JAK-in-the-cell cycle.
In this issue of Blood, Gautier and colleagues describe a novel signaling pathway in which deregulated JAK2 activity augments expression of a key regulator of the cell cycle, the CDC25A phosphatase, via a translational mechanism.
University Medical Center Freiburg.
Heike L
HL
Pahl